TABLE 2.
Effects of SFI in septic shock patients receiving MV in different models.
| Variable | Crude model | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|
| HR (95%CI) | p-value | HR (95%CI) | p-value | HR (95%CI) | p-value | |
| 28-day mortality | 0.766 (0.628–0.933) | 0.008 | 0.752 (0.617–0.917) | 0.005 | 0.749 (0.613–0.914) | 0.004 |
| vasopressor therapy | 0.705 (0.641–0.776) | p < 0.001 | 0.701 (0.637–0.771) | p < 0.001 | 0.704 (0.639–0.775) | p < 0.001 |
| length of ICU stay | 0.734 (0.668–0.808) | p < 0.001 | 0.729 (0.663–0.802) | p < 0.001 | 0.732 (0.665–0.806) | p < 0.001 |
| time to extubation | 0.692 (0.630–0.761) | p < 0.001 | 0.687 (0.625–0.756) | p < 0.001 | 0.687 (0.625–0.756) | p < 0.001 |
| organ failure | 0.814 (0.745–0.889) | p < 0.001 | 0.807 (0.738–0.882) | p < 0.001 | 0.819 (0.749–0.896) | p < 0.001 |
Model 1: adjusted for sex and age.
Model 2: adjusted for sex, age, body mass index, heart rate, blood creatinine, glomerular filtration rate, brain natriuretic peptide, cardiac troponin, creatine kinase isoenzymes, procalcitonin, total bilirubin and prothrombin time.